These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 29879601)
1. Medication and physical activity and physical fitness in severe mental illness. Perez-Cruzado D; Cuesta-Vargas A; Vera-Garcia E; Mayoral-Cleries F Psychiatry Res; 2018 Sep; 267():19-24. PubMed ID: 29879601 [TBL] [Abstract][Full Text] [Related]
2. Impact of antipsychotic medication on physical activity and physical fitness in adolescents: An exploratory study. Vancampfort D; Probst M; Daenen A; Damme TV; De Hert M; Rosenbaum S; Bruyninckx D Psychiatry Res; 2016 Aug; 242():192-197. PubMed ID: 27288738 [TBL] [Abstract][Full Text] [Related]
3. Atypical antipsychotics for nursing home patients: a retrospective chart review. Frenchman IB Drugs Aging; 2005; 22(3):257-64. PubMed ID: 15813657 [TBL] [Abstract][Full Text] [Related]
4. Obsessive-compulsive symptoms in patients with schizophrenia: a naturalistic cross-sectional study comparing treatment with clozapine, olanzapine, risperidone, and no antipsychotics in 543 patients. Scheltema Beduin AA; Swets M; Machielsen M; Korver N; J Clin Psychiatry; 2012 Nov; 73(11):1395-402. PubMed ID: 23218156 [TBL] [Abstract][Full Text] [Related]
5. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups. Curran S; Turner D; Musa S; Wattis J Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576 [TBL] [Abstract][Full Text] [Related]
6. Electroencephalogram Modifications Associated With Atypical Strict Antipsychotic Monotherapies. Dias Alves M; Micoulaud-Franchi JA; Simon N; Vion-Dury J J Clin Psychopharmacol; 2018 Dec; 38(6):555-562. PubMed ID: 30247179 [TBL] [Abstract][Full Text] [Related]
7. The relationship between quality of life and physical fitness in people with severe mental illness. Perez-Cruzado D; Cuesta-Vargas AI; Vera-Garcia E; Mayoral-Cleries F Health Qual Life Outcomes; 2018 May; 16(1):82. PubMed ID: 29720196 [TBL] [Abstract][Full Text] [Related]
8. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone]. Bret P; Bonnet F; Bret MC; Jaffré A Encephale; 2002; 28(4):329-42. PubMed ID: 12232542 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol. Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I; J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069 [TBL] [Abstract][Full Text] [Related]
11. Quetiapine versus other atypical antipsychotics for schizophrenia. Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315 [TBL] [Abstract][Full Text] [Related]
12. Substituting traditional antipsychotics with risperidone for individuals with mental retardation. Simon EW; Blubaugh KM; Pippidis M Ment Retard; 1996 Dec; 34(6):359-66. PubMed ID: 8990820 [TBL] [Abstract][Full Text] [Related]
13. Patients' opinions of olanzapine and risperidone following long-term treatment: results from a cross-sectional survey. McGrath BM; Tempier RP Pharmacopsychiatry; 2005 Jul; 38(4):147-57. PubMed ID: 16025416 [TBL] [Abstract][Full Text] [Related]
14. Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-naïve patients. Arango C; Giráldez M; Merchán-Naranjo J; Baeza I; Castro-Fornieles J; Alda JA; Martínez-Cantarero C; Moreno C; de Andrés P; Cuerda C; de la Serna E; Correll CU; Fraguas D; Parellada M J Am Acad Child Adolesc Psychiatry; 2014 Nov; 53(11):1179-90,1190.e1-4. PubMed ID: 25440308 [TBL] [Abstract][Full Text] [Related]
15. A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial. Sacchetti E; Valsecchi P; Parrinello G; Schizophr Res; 2008 Jan; 98(1-3):55-65. PubMed ID: 17933497 [TBL] [Abstract][Full Text] [Related]
16. The effect of long-term antipsychotic treatment on prolactin. Staller J J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):317-26. PubMed ID: 16768639 [TBL] [Abstract][Full Text] [Related]
17. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone. Aman MG; Gharabawi GM; J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046 [TBL] [Abstract][Full Text] [Related]
18. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. Krzystanek M; Krupka-Matuszczyk I Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416 [TBL] [Abstract][Full Text] [Related]
19. [Metabolic side effects of risperidone in early onset schizophrenia]. Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267 [TBL] [Abstract][Full Text] [Related]
20. Correspondence Between Physical Self-Concept and Participation in, and Fitness Change After, Biweekly Body Conditioning Classes in Sedentary Women. Aasa U; Paulin J; Madison G J Strength Cond Res; 2017 Feb; 31(2):451-461. PubMed ID: 27893472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]